On Thursday, a startup named InduPro, founded by three scientists from Merck — including two who invented the protein mapping technique — revealed its plans to refine the technology and design antibody drugs. InduPro, whose name is a portmanteau of “induced proximity,” has raised $85 million in Series A financing, the company told Endpoints News exclusively.
